Literature DB >> 33041736

Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses.

Ali A Dawood1.   

Abstract

A new coronavirus strain has wreaked havoc on human lives so the WHO was declared as a pandemic since 20th March 2020. The Membrane glycoprotein MP spans the viral envelope and it has a highly conserved glycosylation sequence. AIM: Our study goal was to find out the N-glycosylation, ligand binding sites, and antigenic variations between COVID-19 and other associated viruses.
METHODS: We performed In silico methodologies for serial analysis at both an operational and result/output level is assessed and compared study factors.
RESULTS: We detected high similarity in sequence alignment for >89% between COVID-19 MP and other MP of CoVs. Prediction of N-glycosylation and cytotoxic T-cell epitopes, we identified precisely sites between SARS-CoV-2 MP and Pangolin CoV MP 100%. We also didn't obtain any similarity in ligand binding site residues between MP sequences. Our study didn't reveal any similarity in CTL epitope predication between coronaviruses under study using the CTLPred server.
CONCLUSIONS: Our results exhibit that the membrane glycoprotein of SARS-CoV-2 is closely associated with predecessor SARS-CoVs specifically Pngolin CoV. Prediction of novel CTL epitopes may substantial scopes for the expansion of a peptide-based vaccine for the inhibition virion assembly of SARS-CoV-2.
© 2020 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Antigenicity; COVID-19; CTL epitope; Glycoprotein; Ligand; Pangolin; Proteins

Year:  2020        PMID: 33041736      PMCID: PMC7532767          DOI: 10.1016/j.vacun.2020.09.005

Source DB:  PubMed          Journal:  Vacunas        ISSN: 1576-9887


  5 in total

1.  Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence.

Authors:  Ali Adel Dawood
Journal:  Microb Pathog       Date:  2022-01-22       Impact factor: 3.738

2.  SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.

Authors:  Yang Yang; Yongjian Wu; Xiaojun Meng; Zhiying Wang; Muhammad Younis; Ye Liu; Peihui Wang; Xi Huang
Journal:  Cell Death Differ       Date:  2022-01-12       Impact factor: 12.067

Review 3.  Exploring the Potential of Chemical Inhibitors for Targeting Post-translational Glycosylation of Coronavirus (SARS-CoV-2).

Authors:  Nancy Tripathi; Bharat Goel; Nivedita Bhardwaj; Ram A Vishwakarma; Shreyans K Jain
Journal:  ACS Omega       Date:  2022-07-28

Review 4.  Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.

Authors:  Sayantani Chatterjee; Joseph Zaia
Journal:  Mass Spectrom Rev       Date:  2022-09-29       Impact factor: 9.011

Review 5.  Glycosylation of SARS-CoV-2: structural and functional insights.

Authors:  Asif Shajahan; Lauren E Pepi; Daniel S Rouhani; Christian Heiss; Parastoo Azadi
Journal:  Anal Bioanal Chem       Date:  2021-07-07       Impact factor: 4.478

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.